Optimizing early triage for subclinical cardiovascular-kidney-metabolic syndrome: longitudinal associations, incremental value, and clinical utility of nine insulin resistance surrogates
Cardiovasc Diabetol. 2026 Jun 21. doi: 10.1186/s12933-026-03266-1. Online ahead of print.ABSTRACTBACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome stage 3 represents a critical, yet highly insidious, window of subclinical target organ damage. We aimed to comprehensively compare nine baselin

